Beyfortus

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Clinical Trials Arena
Pfizer
AstraZeneca
Sanofi
Abrysvo
Beyfortus
RSV
Flag link:
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
Flag link:
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
Fierce Pharma
CDC
Sanofi
AstraZeneca
RSV
Beyfortus
Flag link:
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
Flag link:
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
Flag link:
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Biopharma Reporter
Sanofi
AstraZeneca
Sobi
Beyfortus
RSV
Flag link:
Sanofi, AstraZeneca win EMA support for RSV drug in babies
Sanofi, AstraZeneca win EMA support for RSV drug in babies
BioPharma Dive
AstraZeneca
Beyfortus
RSV
Europe
pediatric
infants
Flag link:
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV
Flag link: